The frequency of AML cells was ~ 80 fold, 25 fold, and 100 fold greater in CD34+ engrafted mice compared to CD34− engrafted mice in the peripheral blood, spleen, and BM, respectively (Fig. 2c, d). This evidence concerns the gene CD34 and acute myeloid leukemia.